To further confirm that MG-induced effects on SHP-2 expression are through the RAGE-dependent binding of NFκB-p65 to the SHP-2 promoter, we carried out Electrophoretic Mobility Shift Assays (EMSA) using nuclear extracts. Here, NFKB1 is linked to myasthenia gravis.